# Evaluation of the Cardiac Effects of a Novel Food Ingredient in Healthy Male Subjects

> **NCT02616913** · NA · COMPLETED · sponsor: **Cargill** · enrollment: 48 (actual)

## Conditions studied

- Cardiovascular Abnormalities

## Interventions

- **OTHER:** R,R-monatin
- **OTHER:** Moxifloxacin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02616913
- **Lead sponsor:** Cargill
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-06
- **Final completion:** 2013-10
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2015-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02616913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02616913, "Evaluation of the Cardiac Effects of a Novel Food Ingredient in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02616913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*